Browse AMR Genes
Explore antimicrobial resistance genes from the literature
Explore antimicrobial resistance genes from the literature
broad-spectrum class A beta-lactamase CfxA5
Overview
| Allele | Database | Papers | Drug Classes | Organisms | Countries | Years | Sequence Accession | Protein Accession |
|---|---|---|---|---|---|---|---|---|
| CfxA5 | Card DatabaseReference Gene CatalogResFinder DatabaseReslit | 4 | UNKNOWN BETA-LACTAM, CEPHALOSPORIN +1 | Parabacteroides distasonis +1 | North America|Eastern Europe | 2014, 2020 | AY769934.1 | AAV37206.1 |
| cfxA5 | ResFinder Database | 1 | UNKNOWN BETA-LACTAM | Parabacteroides distasonis | - | - | AY769934 | - |
Phenotypic and genotypic characterization of multidrug-resistant Bacteroides, Parabacteroides spp., and Pseudoflavonifractor from a Costa Rican hospital.
Phenotypic and genotypic characterization of multidrug-resistant Bacteroides, Parabacteroides spp., and Pseudoflavonifractor from a Costa Rican hospital.
Phenotypic and genotypic characterization of multidrug-resistant Bacteroides, Parabacteroides spp., and Pseudoflavonifractor from a Costa Rican hospital.
Ribaxamase, an Orally Administered beta-lactamase, Diminishes Changes to Acquired Antimicrobial Resistance of the Gut Resistome in Patients Treated with Ceftriaxone.
The study identified several beta-lactamase and vancomycin resistance genes that were significantly increased in placebo-treated patients compared to ribaxamase-treated patients following ceftriaxone exposure.
No comments yet. Be the first to comment!